2024-05-10T15:28:23-05:00 2023-06-30 861065772 DELOITTE TAX LLP 111 MONUMENT CIRCLE SUITE 4200 INDIANAPOLIS IN 462045108 990 2022-07-01 351044585 AMERICAN LEBANESE SYRIAN ASSOCIATED CHARITIES INC AMER 9015782000 501 ST JUDE PLACE MEMPHIS TN 38105 KERA WRIGHT CHIEF FINANCIAL OFFICER 9015782510 2024-05-10 1 KERA WRIGHT 999009999 0 SHAWNA M JANSONS P01222873 3174648600 2 AAL1 IAL1 2022 2023-04-26 12:10:37Z RICHARD C SHADYAC JR 501 ST JUDE PLACE MEMPHIS TN 38105 5729224130 0 X WWW.STJUDE.ORG X 1957 IL TO RAISE FUNDS AND BUILD AWARENESS TO SUSTAIN AND GROW THE MISSION OF ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. 37 35 2109 1000000 1491172 0 2370493980 2405127358 0 0 488360509 236051572 31538605 45450490 2890393094 2686629420 1083764954 1367277418 0 0 206632282 231907353 14687759 14411084 403442652 514238788 590167547 1819323783 2203763402 1071069311 482866018 8359227655 9109419712 124572152 142305459 8234655503 8967114253 X AMERICAN LEBANESE SYRIAN ASSOCIATED CHARITIES, INC. (ALSAC) WAS FOUNDED IN 1957 AND EXISTS SOLELY TO RAISE FUNDS AND BUILD AWARENESS TO SUSTAIN AND GROW THE MISSION OF ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. TO ADVANCE CURES, AND MEANS OF PREVENTION, FOR PEDIATRIC CATASTROPHIC DISEASES THROUGH RESEARCH AND TREATMENT WHILE HONORING THE MEMORY AND HERITAGE OF OUR FOUNDER, DANNY THOMAS. 0 0 1606142118 1367277418 37231324 ALSAC IS THE FUNDRAISING AND AWARENESS ORGANIZATION FOR ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. (ST. JUDE). ALSAC EXISTS SOLELY TO RAISE THE FUNDS AND AWARENESS NEEDED TO SUSTAIN AND GROW ST. JUDE NOW AND IN THE FUTURE. ALSAC IS CHARGED WITH SUPPORTING THE MISSION OF ST. JUDE CHILDREN'S RESEARCH HOSPITAL TO ADVANCE CURES, AND MEANS OF PREVENTION, FOR PEDIATRIC CATASTROPHIC DISEASES THROUGH RESEARCH AND TREATMENT WHILE HONORING THE MEMORY AND HERITAGE OF OUR FOUNDER, DANNY THOMAS. THANKS TO GENEROUS DONORS, FAMILIES NEVER RECEIVE A BILL FROM ST. JUDE FOR TREATMENT, TRAVEL, HOUSING OR FOOD - SO THEY CAN FOCUS ON HELPING THEIR CHILD LIVE. (CONTINUED ON SCHEDULE O) 1606142118 1 1 0 1 0 0 0 0 0 1 1 1 0 0 1 1 1 1 0 0 1 0 0 1 1 1 0 1 0 1 0 0 0 0 0 0 1 1 1 1 0 0 0 1 1 1 0 0 1 X 1234 95 1 2109 1 1 1 1 AS BD BR VI CA CH CJ DA EI FR GK GM HK IN IT JA MP MX NL SP SW SZ TW UK 0 0 0 1 1 0 0 0 0 1 0 X 37 35 1 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 AL CA CO CT FL GA HI IL KS KY MA MD MI MN MS NC NH NJ NM NY OH OK OR PA RI SC TN UT WA WI WV X X X KERA WRIGHT 9015782150 501 ST JUDE PLACE MEMPHIS TN 38105 RICHARD C SHADYAC JR CEO & EX-OFFICIO DIRECTOR 55.00 1.00 X X 1209731 0 152180 JAMES R DOWNING EX-OFFICIO DIRECTOR 1.00 55.00 X 0 1591162 259945 JOYCE ABOUSSIE VOTING DIRECTOR 4.00 4.00 X 0 0 0 STEVEN J ALLEN MD VOTING DIRECTOR 4.00 4.00 X 0 0 0 JOSEPH S AYOUB JR ESQ VOTING DIRECTOR 4.00 4.00 X 0 0 0 PAUL J AYOUB ESQ VOTING DIRECTOR 4.00 8.00 X 0 0 0 FREDERICK M AZAR MD VOTING DIRECTOR 8.00 4.00 X 0 0 0 MARTHA PERINE BEARD VOTING DIRECTOR 8.00 4.00 X 0 0 0 ROBERT A BREIT MD VOTING DIRECTOR 4.00 4.00 X 0 0 0 TERRY L BURMAN VOTING DIRECTOR 4.00 4.00 X 0 0 0 ANN M DANNER VOTING DIRECTOR 4.00 4.00 X 0 0 0 JOSEPH M DEVIVO VOTING DIRECTOR 4.00 4.00 X 0 0 0 LISA R DILLER MD VOTING DIRECTOR 4.00 4.00 X 0 0 0 JOSEPH E EID MD VOTING DIRECTOR 4.00 4.00 X 0 0 0 FRED P GATTAS III PHARMD VOTING DIRECTOR 4.00 4.00 X 0 0 0 JUDY HABIB VOTING DIRECTOR 4.00 8.00 X 0 0 0 GABRIEL HADDAD MD VOTING DIRECTOR 4.00 4.00 X 0 0 0 CHARLES C HAJJAR VOTING DIRECTOR 4.00 4.00 X 0 0 0 FOUAD HAJJAR MD VOTING DIRECTOR 4.00 4.00 X 0 0 0 FREDERICK R HARRIS JR MD VOTING DIRECTOR 4.00 8.00 X 0 0 0 J DAVID KARAM II VOTING DIRECTOR 8.00 4.00 X 0 0 0 SCOTT A KUPOR VOTING DIRECTOR 4.00 4.00 X 0 0 0 SHARON L MCCOLLAM VOTING DIRECTOR 4.00 4.00 X 0 0 0 MICHAEL D MCCOY VOTING DIRECTOR 4.00 4.00 X 0 0 0 ROBERT T MOLINET ESQ VOTING DIRECTOR 4.00 4.00 X 0 0 0 RAMZI NUWAYHID VOTING DIRECTOR 4.00 4.00 X 0 0 0 THOMAS PENN III VOTING DIRECTOR 4.00 4.00 X 0 0 0 CHRISTINA M RASHID VOTING DIRECTOR 4.00 4.00 X 0 0 0 CAMILLE F SARROUF JR ESQ VOTING DIRECTOR 4.00 4.00 X 0 0 0 JOSEPH C SHAKER VOTING DIRECTOR 4.00 4.00 X 0 0 0 JOSEPH G SHAKER VOTING DIRECTOR 4.00 4.00 X 0 0 0 GEORGE A SIMON II VOTING DIRECTOR 4.00 4.00 X 0 0 0 MICHAEL SIMON VOTING DIRECTOR 4.00 4.00 X 0 0 0 TONY THOMAS VOTING DIRECTOR 4.00 4.00 X 0 0 0 RICHARD M UNES VOTING DIRECTOR 4.00 4.00 X 0 0 0 PAUL H WEIN ESQ VOTING DIRECTOR 4.00 4.00 X 0 0 0 TAMA H ZAYDON VOTING DIRECTOR 4.00 4.00 X 0 0 0 IKSHIT ANAND CHIEF OPERATING OFFICER 55.00 0.00 X 557774 0 88918 KERA WRIGHT CHIEF FINANCIAL OFFICER 55.00 0.00 X 465796 0 66928 ANURAG PANDIT CHIEF INVESTMENT OFFICER 55.00 0.00 X 661006 0 99135 STEVE FROEHLICH CHIEF REVENUE OFFICER 55.00 0.00 X 527172 0 114076 EMILY CALLAHAN CHIEF MARKETING & EXPERIENCE OFFICER 55.00 0.00 X 623963 0 113776 SARA HALL CHIEF LEGAL OFFICER 55.00 0.00 X 575984 0 107090 MELANEE HANNOCK CHIEF DIGITAL AND INNOVATION 55.00 0.00 X 539232 0 104989 GEORGE SHADROUI SR. FELLOW - STRATEGIC INITIATIVES 55.00 0.00 X 546667 0 89050 MARTIN HAND CHIEF DONOR OFFICER 55.00 0.00 X 485329 0 89571 ABED ABDO FORMER OFFICER 55.00 0.00 X 325931 0 15235 EMILY GREER FORMER OFFICER 0.00 0.00 X 301224 0 5456 6819809 1591162 1306349 614 1 1 0 INTERNAL DATA RESOURCES 1120 SANCTUARY PARKWAY STE 150 ALPHARETTA GA 30009 IT CONTRACT LABOR 9636956 EAGLECOM INC 2300 YONGE STREET STE 1700 TORNOTO ONTARIO CA 60654 MEDIA PURCHASING 8200618 VACO LLC PO BOX 667 BRENTWOOD TN 37024 IT CONTRACT LABOR 8122262 INFOCISION MANAGEMENT CORPORATION 325 SPRINGSIDE DRIVE AKRON OH 443334501 CALL CENTER 7423895 DATA AXLE INC (INFOGROUP INC) PO BOX 3243 OMAHA NE 68103 MARKETING & DATA 4949093 202 3165068 15956789 2386005501 86369650 2405127358 68840175 260904 68579271 7500 0 7500 7500 7500 3180977757 198522 3013805408 159474 167172349 39048 167211397 167211397 17454501 15956789 10473103 6981398 6981398 53127922 15896598 37231324 37231324 3490395 2260127 1230268 1230268 2686629420 37231324 1491172 242779566 X 1367277418 1367277418 3978665 794468 1298886 1885311 343810 68652 112241 162917 180635672 36013211 59090819 85531642 11502329 2287613 3645573 5569143 22731925 4505976 6759059 11466890 12714952 2554565 4063014 6097373 2646557 398032 1070188 1178337 593844 593844 40000 40000 14411084 14411084 30786553 6181333 10150352 14454868 610670 100966 346550 163154 24180567 4673271 12128667 7378629 11821387 2026235 4985053 4810099 9689038 1805211 2468726 5415101 5690489 1965740 1016824 2707925 31723927 4814343 25894487 1015097 4732942 817655 2094140 1821147 CAMPAIGN EXPENSES 244768737 104983806 13452919 126332012 MAILINGS & SHIPPING 149293523 50990149 18149854 80153520 TELECOMMUNICATIONS 6031787 1870632 2435168 1725987 PRINTING & PUBLICATION 2984828 535874 372132 2076822 64572698 11476968 24050136 29045594 2203763402 1606142118 194178632 403442652 X 199256005 110262243 17782942 71210820 73479037 407683641 355601830 88346172 52857093 308555 1986867 3171054 2703711 16548978 40808849 461852237 220099153 222213984 241753084 7620955271 8340229241 8359227655 9109419712 79016079 96998160 45556073 45307299 124572152 142305459 X 6995147248 7674244381 1239508255 1292869872 8234655503 8967114253 8359227655 9109419712 482866018 249594054 -1322 0 X 0 1 X 1 0 X 1667190856 1744366291 2024430417 2370493980 2405127358 10211608902 1667190856 1744366291 2024430417 2370493980 2405127358 10211608902 10211608902 35719999 25296657 33208256 49898672 68847676 212971260 0 0 0 2425818 0 2425818 10427005980 276117678 0.97930 0.95550 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 0 0 0 0 0 0 0 1 40000 40000 0 PART II-B, LINE 1: ENGAGE LOBBYIST REGARDING CURRENT LAWS AND PROPOSED LEGISLATION ON REAL ESTATE RAFFLE PRIZES. 1209550774 2023095 70264947 16018922 1265819894 1329927343 9150000 -59754448 69772121 1209550774 1033682990 7863768 357550674 69170089 1329927343 1055350944 5491426 34726892 61886272 1033682990 1024698330 4864242 64664085 38875713 1055350944 0.08900 0.91100 1 0 46303675 46303675 152418860 46782082 105636778 5612364 4218448 1393916 73229264 16860795 56368469 184288074 152237828 32050246 241753084 GLOBAL EQUITY 3206604699 F MARKETABLE ALTERNATIVES 1969661713 F REAL ASSETS 295805395 F PRIVATE EQUITY 1887197335 F FIXED INCOME 891749549 F CASH EQUIVALENTS 89210550 F 8340229241 ANNUITY OBLIGATIONS 45307299 45307299 X 2952118750 249594054 249594054 2702524696 -15895276 -15895276 2686629420 2219660000 15896598 15896598 2203763402 0 2203763402 PART V, LINE 4: THE INTENDED USE OF THE ORGANIZATION'S RESERVE FUND IS TO SUPPORT THE CURRENT AND FUTURE NEEDS OF ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. THE FUND HELPS ENSURE THAT ST. JUDE CAN CONTINUE ITS COMMITMENT TO TREATING PATIENTS AND ADVANCING LONG-TERM RESEARCH PROJECTS IN THE YEARS AHEAD - NO MATTER WHAT HAPPENS IN THE ECONOMY OR IN THE EVENT OF A DISASTER. IT CURRENTLY COSTS NEARLY $2 BILLION TO SUSTAIN AND GROW ST. JUDE EVERY YEAR, AND THE COST IS ESTIMATED TO GROW TO MORE THAN $2.2 BILLION PER YEAR BY 2027. IN THE YEARS AHEAD AN ESTIMATED 89% OF THE FUNDS NECESSARY TO SUSTAIN AND GROW ST. JUDE MUST BE RAISED BY ALSAC. TREATMENTS FOR PEDIATRIC CANCER AT ST. JUDE CAN LAST UP TO 3 YEARS OR MORE WITH AN AVERAGE COST OF APPROXIMATELY $450,000 (AND COULD EXCEED $1 MILLION) PER PATIENT, INCLUDING HOUSING, TRAVEL, AND FOOD BUT THE INDIVIDUAL COST OF CARE CAN VARY GREATLY. YET REGARDLESS OF COST, FAMILIES NEVER RECEIVE A BILL FROM ST. JUDE FOR TREATMENT, TRAVEL, HOUSING OR FOOD - SO THEY CAN FOCUS ON HELPING THEIR CHILD LIVE. IN ADDITION, CARE DOESN'T END WHEN TREATMENT IS FINISHED - ST. JUDE FOLLOWS PATIENTS FOR LIFE, LEARNING FROM YESTERDAY'S PATIENTS TO IMPROVE CARE AND OUTCOMES FOR TOMORROW'S CHILDREN. THE RESERVE FUND HELPS ENSURE THAT ST. JUDE CAN FULFILL THAT COMMITMENT TO EACH AND EVERY PATIENT, NOW AND INTO THE FUTURE, REGARDLESS OF THE COST OR DURATION OF THEIR CARE. THE RESERVE FUND ALSO PROVIDES CONFIDENCE FOR ST. JUDE TO CONTINUE ADVANCING ITS SIX-YEAR, $12.9 BILLION STRATEGIC PLAN TO EXPAND PATIENT SERVICES AND ACCELERATE RESEARCH IN THE U.S. AND GLOBALLY FOR CHILDREN WITH CATASTROPHIC DISEASES. IT ALSO ENSURES OUR ABILITY TO SUPPORT A SIX-YEAR, $200 MILLION PARTNERSHIP WITH THE WORLD HEALTH ORGANIZATION (WHO), ANNOUNCED IN 2021, TO DRAMATICALLY INCREASE ACCESS TO HIGH-QUALITY CANCER MEDICINES FOR CHILDREN IN LOW- AND MIDDLE-INCOME COUNTRIES FREE OF CHARGE - THE LARGEST FINANCIAL COMMITMENT EVER MADE FOR A GLOBAL EFFORT IN PEDIATRIC CANCER MEDICATIONS, AND THE FUND HELPS ST. JUDE TO LAUNCH MULTIPLE LONG-TERM RESEARCH STUDIES, WITH ASSURANCE OF FUNDING TO SEE THEM THROUGH COMPLETION. CURING CATASTROPHIC DISEASES IN CHILDREN IS A MULTI-TRILLION-DOLLAR, MULTI-YEAR GLOBAL PROBLEM AND ST. JUDE MUST CONTINUE OUR WORK NO MATTER WHAT HAPPENS WITH THE ECONOMY, THE MARKET, FUNDRAISING OR IN THE EVENT OF A DISASTER. PART X, LINE 2: AS OF JUNE 30, 2023, ALSAC HAD NOT IDENTIFIED ANY UNCERTAIN TAX POSITIONS UNDER ASC TOPIC 740, INCOME TAXES, REQUIRING ADJUSTMENTS TO ITS FINANCIAL STATEMENTS. IN THE EVENT ALSAC WERE TO RECOGNIZE INTEREST AND PENALTIES RELATED TO UNCERTAIN TAX POSITIONS, IT WOULD BE RECOGNIZED IN THE FINANCIAL STATEMENTS AS A GENERAL EXPENSE. GENERALLY, TAX YEARS ENDING 2020 THROUGH 2023 ARE OPEN TO EXAMINATION BY THE FEDERAL AND STATE TAXING AUTHORITIES, RESPECTIVELY. THERE ARE NO INCOME TAX EXAMINATIONS CURRENTLY IN PROCESS. PART XI, LINE 4B - OTHER ADJUSTMENTS: DIRECT GAMING EXPENSES -15,895,276. PART XII, LINE 2D - OTHER ADJUSTMENTS: DIRECT GAMING EXPENSES 15,896,598. DIRECT GAMING EXPENSES INDENTIFIED ABOVE REFER TO THE ST. JUDE DREAM HOME GIVEAWAYS. CENTRAL AMERICA AND THE CARIBBEAN INVESTMENTS 2464618219 EAST ASIA AND THE PACIFIC INVESTMENTS 18328749 EUROPE (INCLUDING ICELAND & GREENLAND) INVESTMENTS 144998578 MIDDLE EAST AND NORTH AFRICA INVESTMENTS 1965054 NORTH AMERICA INVESTMENTS 21626932 SOUTH AMERICA INVESTMENTS 900579 SOUTH ASIA INVESTMENTS 5974389 SUB-SAHARAN AFRICA INVESTMENTS 10458738 CENTRAL AMERICA AND THE CARIBBEAN 0 0 PROGRAM SERVICES EDUCATION AND TRAINING 50000 EAST ASIA AND THE PACIFIC 0 0 PROGRAM SERVICES EDUCATION AND TRAINING 17000 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 PROGRAM SERVICES EDUCATION AND TRAINING 17000 NORTH AMERICA 0 0 PROGRAM SERVICES EDUCATION AND TRAINING 83000 RUSSIA AND NEIGHBORING STATES 0 0 PROGRAM SERVICES EDUCATION AND TRAINING 17000 SOUTH AMERICA 0 0 PROGRAM SERVICES EDUCATION AND TRAINING 100000 SOUTH ASIA 0 0 PROGRAM SERVICES EDUCATION AND TRAINING 17000 SUB-SAHARAN AFRICA 0 0 PROGRAM SERVICES EDUCATION AND TRAINING 174000 0 0 0 0 0 0 2668871238 475000 2669346238 1 0 1 1 1 0 PART III ACCOUNTING METHOD: PART I, LINE 3: EXPENDITURES ARE RECORDED ON AN ACCRUAL BASIS. X X X X X X 1 INFOCISION MANAGEMENT CORP 325 SPRINGSIDE DR AKRON OH 443334501 FUNDRAISING SOLICITOR 0 5412336 5093201 319135 COMMSENSE LLC MONTANA INDUSTRIAL PARK ROAD 459 KM AGUADILLA RQ 00603 FUNDRAISING SOLICITOR 0 212812 57061 155751 EAGLECOMM INC 2300 YONGE STREET SUITE 1700 BOX TORONTO ONTARIO CA M4P 1E4 FUNDRAISING COUNSEL 0 0 8892222 -8892222 NNE MARKETING LLC 1666 MASSACHUSETTS AVE SUITE 14 LEXINGTON MA 02420 FUNDRAISING COUNSEL 0 0 240000 -240000 VERITUS GROUP 1105 WASHINGTON BLVD 186 BELPRE OH 45714 FUNDRAISING COUNSEL 0 0 128600 -128600 5625148 14411084 -8785936 AK AL AR CA CO CT DC FL GA HI IL KS KY LA MA MD ME MI MN MO MS NC ND NH NJ NM NV NY OH OK OR PA RI SC TN UT VA WA WI WV GALA 2550676 1113894 1436782 41675 64346 161390 38867 GALA 1437520 591937 845583 16510 177745 167551 170773 274881 173 29423094 14250958 15172136 227925 2183137 2271387 2543236 2133680 33411290 15956789 17454501 244435 2402557 2503284 2875399 2447428 10473103 6981398 53127922 10104935 26251 5765412 0 53127922 10104935 26251 5765412 15896598 37231324 CA CO GA ID IL KS KY LA MA MO MT MS NC NM NV NY OH OK TN TX VA 0 IN COLORADO, ALSAC CONTRACTS WITH A THIRD PARTY WHO IS LICENSED TO CONDUCT GAMING IN THAT STATE. SEE RESPONSE TO SCHEDULE G, PART III, LINES 15A - C. LICENSES ARE NOT REQUIRED FOR THE GAMING ACTIVITY CONDUCTED BY ALSAC IN THE FOLLOWING STATES LISTED ON LINE 9 ABOVE: MO, MS, MT, NC, OH, OK AND TX. LICENSES ARE REQUIRED FOR THE GAMING ACTIVITY CONDUCTED BY ALSAC IN THE FOLLOWING STATES LISTED ON LINE 9 ABOVE: CA, GA, ID, IL, KS, KY, LA, MA, NM, NV, NY, TN AND VA. 0 1 0 0.05000 0.95000 KERA WRIGHT 501 ST JUDE PLACE MEMPHIS TN 38105 1 1965000 0 EPSILON SIGMA ALPHA CHAPTER OF COLORADO 363 WEST DRAKE ROAD FORT COLLINS CO 80526 BRIAN DOYLE 181823 MANAGES THE PLANNING, EXECUTION, AND OVERSIGHT OF GAMING ACTIVITIES X 1 20955765 SCHEDULE G, PART III, COLUMN (C), OTHER GAMING: THE ST. JUDE DREAM HOME CAMPAIGN IS A NATIONWIDE PROGRAM TO FURTHER ALSAC'S MISSION TO RAISE FUNDS AND AWARENESS OF THE PROGRAMS AND SERVICES THAT ST. JUDE CHILDREN'S RESEARCH HOSPITAL PROVIDES, SPECIFICALLY, WITH RESPECT TO ITS ROLE IN LEADING THE WAY THE WORLD UNDERSTANDS, TREATS AND DEFEATS CHILDHOOD CANCER AND OTHER LIFE-THREATENING CHILDHOOD DISEASES. IN CONNECTION WITH THE OPPORTUNITY TO PURCHASE A RAFFLE TICKET FOR THE OPPORTUNITY TO WIN A HOME, THE ST. JUDE DREAM HOME CAMPAIGN PROVIDES NATIONAL REACH AND MARKETING EXPOSURE FOR ALSAC'S MISSION TO SUPPORT THE MISSION OF ST. JUDE. OVER 6.3 MILLION WEBSITE PAGE VIEWS, AN ESTIMATED 22,000 TV AND RADIO PLACEMENTS, OVER 8.9 MILLION PIECES OF DIRECT MAIL, PRESENCE IN 42 MARKETS NATIONWIDE IN 18 SEPARATE STATES, OVER 31 MILLION SOCIAL MEDIA IMPRESSIONS, 3.1 MILLION EMAILS DEPLOYED AND AN ESTIMATED 600 PLUS BROADCAST NEWS STORIES TO SPREAD INFORMATION ABOUT THE MISSION OF ST. JUDE ARE JUST A FEW OF THE RESULTS ACHIEVED BY THIS CAMPAIGN. ALTHOUGH NATIONAL IN SCOPE, THE CAMPAIGN IS DIRECTED TO SPECIFIC, TARGETED MARKETS WHERE A MARKETING OUTREACH CAMPAIGN CAN RESULT IN STRONG AWARENESS FOR THE MISSION OF ST. JUDE. THE EXTENSIVE AND INTENSIVE COMMUNITY ENGAGEMENT SURROUNDING THE ST. JUDE DREAM HOME EVENTS IS DESIGNED TO ENGAGE THE PUBLIC IN THE AWARENESS CAMPAIGN ABOUT ST. JUDE, EXPOSING LARGE NUMBERS IN THE COMMUNITY TO THE ALSAC/ST. JUDE MISSION REGARDLESS OF WHETHER AN INDIVIDUAL PURCHASES A RAFFLE TICKET. THE MARKETING EFFORTS ASSOCIATED WITH THE ST. JUDE DREAM HOME CAMPAIGN CONTRIBUTE IMPORTANTLY TO RAISING THE AWARENESS NECESSARY TO INCREASING COMMUNITY ENGAGEMENT WITH ST. JUDE CHILDREN'S RESEARCH HOSPITAL (INCLUDING TAKING ADVANTAGE OF THE IMPORTANT SERVICES ST. JUDE PROVIDES), AS WELL AS TO ATTRACT AND RETAIN NEW DONORS TO ENSURE THE CONTINUED OPERATION OF ST. JUDE NOW AND IN THE FUTURE, WHILE ALSO ENSURING THAT NO FAMILY EVER RECEIVES A BILL FROM ST. JUDE FOR TREATMENT, TRAVEL, HOUSING OR FOOD. THE ST. JUDE DREAM HOME CAMPAIGN, THROUGH THE TELEVISION AND RADIO PROGRAMS, PLACEMENTS, FUNDRAISING AND PUBLIC AWARENESS EVENTS, ALSO BENEFITS OUR EDUCATION, TRAINING AND COMMUNITY SERVICE PROGRAM OBJECTIVES THAT SUPPORT THE ST. JUDE MISSION AND ABILITY TO CONTINUE TO LEAD THE WAY THE WORLD UNDERSTANDS, TREATS AND DEFEATS CHILDHOOD CANCER AND OTHER LIFE-THREATENING DISEASES. PART III, LINE 17B, MANDATORY DISTRIBUTIONS BY STATE: CA - $ 2,766,964 ID - $2,135,912 IL - $922,858 KY - $623,292 LA - $4,882,720 MS - $1,005,135 MO - $1,742,728 MT - $831,138 NC - $2,206,831 NV - $1,067,349 NY - $35,891 TN - $1,424,613 VA - $391,954 1 ST JUDE CHILDREN'S RESEARCH HOSPITAL INC 262 DANNY THOMAS PLACE MEMPHIS TN 38105 620646012 501(C)(3) 1367277418 0 SUPPORT FOR OPERATIONAL AND CAPITAL BUDGET NEEDS 1 0 PART I, LINE 2: THE SOLE RECIPIENT OF GRANTS AND SUPPORT IS ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. ALSAC IS THE FUNDRAISING AND AWARENESS ORGANIZATION FOR ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. ALSAC EXISTS SOLELY TO RAISE FUNDS AND BUILD AWARENESS TO SUSTAIN AND GROW THE MISSION OF ST. JUDE. X X 1 1 X X X X X X 1 1 0 0 0 0 0 0 0 JAMES R DOWNING EX-OFFICIO DIRECTOR 0 1328031 0 254200 0 8931 0 232550 0 27395 0 1851107 0 0 RICHARD C SHADYAC JR CEO & EX-OFFICIO DIRECTOR 1123515 0 0 0 86216 0 125869 0 26311 0 1361911 0 77072 0 ANURAG PANDIT CHIEF INVESTMENT OFFICER 626180 0 0 0 34826 0 72640 0 26495 0 760141 0 30074 0 EMILY CALLAHAN CHIEF MARKETING & EXPERIENCE OFFICER 588230 0 0 0 35733 0 83056 0 30720 0 737739 0 35013 0 SARA HALL CHIEF LEGAL OFFICER 532688 0 0 0 43296 0 76619 0 30471 0 683074 0 41640 0 IKSHIT ANAND CHIEF OPERATING OFFICER 555275 0 0 0 2499 0 58585 0 30333 0 646692 0 1419 0 MELANEE HANNOCK CHIEF DIGITAL AND INNOVATION 501691 0 0 0 37541 0 74502 0 30487 0 644221 0 35885 0 STEVE FROEHLICH CHIEF REVENUE OFFICER 502416 0 0 0 24756 0 75918 0 38158 0 641248 0 0 0 GEORGE SHADROUI SR. FELLOW - STRATEGIC INITIATIVES 498443 0 0 0 48224 0 74078 0 14972 0 635717 0 39080 0 MARTIN HAND CHIEF DONOR OFFICER 455708 0 0 0 29621 0 62179 0 27392 0 574900 0 0 0 KERA WRIGHT CHIEF FINANCIAL OFFICER 458075 0 0 0 7721 0 53922 0 13006 0 532724 0 6641 0 ABED ABDO FORMER OFFICER 80224 0 0 0 245707 0 9392 0 5843 0 341166 0 0 0 EMILY GREER FORMER OFFICER 286826 0 0 0 14398 0 4573 0 883 0 306680 0 0 0 PART I, LINE 1A HEALTH OR SOCIAL CLUB DUES: A SOCIAL CLUB MEMBERSHIP WAS MADE AVAILABLE TO THE CEO BUT LIMITED TO BUSINESS PURPOSES IN ACCORDANCE WITH A WRITTEN POLICY DIRECTIVE. THE AMOUNT OF THE MEMBERSHIP WAS NOT TREATED AS TAXABLE INCOME BECAUSE THE USE WAS BUSINESS RELATED. ONE FORMER OFFICER RECEIVED A GROSS-UP DURING THE YEAR. THE GROSS-UP WAS TREATED AS TAXABLE WAGES TO THE RECIPIENT. PART I, LINE 4A: UNDER A VOLUNTARY SEPARATION AGREEMENT ENTERED INTO BY THE EMPLOYEE AND THE ORGANIZATION, THE EMPLOYEE IS ENTITLED TO SEVERANCE PAY. THE TERMS AND CONDITIONS TO RECEIVE SEVERANCE ARE CONFIDENTIAL. ALL SEVERANCE AGREEMENTS, WHEN LEGALLY PERMITTED INCLUDE A RELEASE OF CLAIMS. SEVERANCE PAYMENTS WERE MADE DURING THE YEAR TO THE FOLLOWING LISTED PERSONS IN PART VII. ABED ABDO $192,427. PART I, LINE 4B: THE ORGANIZATION ESTABLISHED A NON-QUALIFIED DEFERRED COMPENSATION PLAN PURSUANT TO CODE SECTION 457(F) OF THE INTERNAL REVENUE CODE. THE PLAN AMOUNTS ARE SUBJECT TO SUBSTANTIAL FUTURE SERVICE REQUIREMENTS TO THE ORGANIZATION AND ARE SUBJECT TO SUBSTANTIAL RISK OF FORFEITURE. NONQUALIFIED PLAN PAYMENTS WERE MADE DURING THE YEAR TO THE FOLLOWING LISTED PERSONS IN PART VII: ABED ABDO $737 EMILY CALLAHAN $23,282 EMILY GREER $194,467 COURY SHADYAC SEE PART V 365664 EMPLOYMENT 0 SUBSTANTIAL CONTRIBUTOR SEE PART V 4727672 SEE PART V 0 SCHEDULE L, PART IV, BUSINESS TRANSACTIONS INVOLVING INTERESTED PERSONS: (A) NAME OF INTERESTED PERSON: COURY SHADYAC, SR. VICE PRESIDENT - TERRITORIES(B) RELATIONSHIP BETWEEN INTERESTED PERSON AND ORGANIZATION: FAMILY MEMBER OF OFFICER (CEO & EX-OFFICIO DIRECTOR), RICHARD C. SHADYAC, JR.(C) AMOUNT OF TRANSACTION: $365,644(D) DESCRIPTION OF TRANSACTION: EMPLOYMENT(E) SHARING OF ORGANIZATION REVENUES? = NO SCHEDULE L, PART IV, BUSINESS TRANSACTIONS INVOLVING INTERESTED PERSONS: (A) NAME OF INTERESTED PERSON: SUBSTANTIAL CONTRIBUTOR(B) RELATIONSHIP BETWEEN INTERESTED PERSON AND ORGANIZATION: SUBSTANTIAL CONTRIBUTOR(C) AMOUNT OF TRANSACTION: $4,727,672(D) DESCRIPTION OF TRANSACTION: CREDIT CARD PROCESSING SERVICES(E) SHARING OF ORGANIZATION REVENUES? = NO X 42 X 2246 85369650 COST OR SELLING PRICE X 18 X 67 X DIGITAL ASSETS 362 901400 COST OR SELLING PRIC X PRIZE PACKAGE 315 0 X GIFT CARDS & GIFT CERTIFICATES 104 0 X OTHER PRIZES 312 0 6 0 1 1 PART I, COLUMN (B): THE NUMBERS IN COLUMN (B) REFER TO A COMBINATION OF THE NUMBER OF CONTRIBUTIONS AND THE NUMBER OF ITEMS RECEIVED. PART I, LINE 32B: ALSAC PARTNERED WITH CHARITABLE ADULT RIDES (CARS) FOR SALE OF VEHICLES DONATED TO THE ORGANIZATION. CARS WORKS WITH VENDORS THROUGHOUT THE COUNTRY TO PICK-UP DONATIED VEHICLES AND SELL THE VEHICLE. ALSAC ALSO PARTNERED WITH CARS TO ALLOW SUPPORTERS TO DONATE VEHICLES DIRECTLY TO CARS WITH THE PROCEEDS FROM THE SALE BENEFITING THE ORGANIZATION. PART I, LINE 33: RECEIPTS FOR LINES 1, 6, 7, 15, 18, 26, 27, AND 28 ARE REPORTED ON THE FORM 990, PART VIII, LINE 8A OR LINE 9A. FORM 990, PART III, LINE 4A: CURING CATASTROPHIC DISEASES IN CHILDREN IS A MULTI-TRILLION-DOLLAR, MULTI-YEAR GLOBAL PROBLEM AND ALSAC AND ST. JUDE MUST CONTINUE OUR WORK NO MATTER WHAT HAPPENS WITH THE ECONOMY, THE MARKET, FUNDRAISING OR IN THE EVENT OF A DISASTER. IT COSTS NEARLY $2 BILLION A YEAR TO SUSTAIN AND GROW ST. JUDE AND THE COST IS ESTIMATED TO GROW TO $2.2 BILLION BY 2027. ST. JUDE IS A SPECIALTY RESEARCH HOSPITAL FOR CHILDREN, NOT A GENERAL CHILDREN'S HOSPITAL SO NONE OF THE CUTTING-EDGE RESEARCH COSTS AND MANY OF THE EXTENSIVE TREATMENTS AND SERVICES WE PROVIDE ARE NOT COVERED BY INSURANCE, AND MAY NOT BE IN THE FUTURE. UNLIKE OTHER HOSPITALS THAT RECEIVE 90-95% OPERATING REVENUES FROM INSURANCE RECOVERIES AND PATIENT COPAYS, THE MAJORITY OF OUR FUNDING COMES FROM GENEROUS DONORS AND INVESTMENT INCOME TO SUPPORT NEEDS NOW AND IN THE FUTURE. IN THE YEARS AHEAD, AN ESTIMATED 89% OF THE FUNDS NECESSARY TO RUN ST. JUDE MUST BE RAISED BY ALSAC FROM GENEROUS DONORS. WHEN ST. JUDE OPENED ITS DOORS IN 1962, CHILDHOOD CANCER WAS LARGELY CONSIDERED INCURABLE. SINCE THEN, ST. JUDE HAS HELPED PUSH THE OVERALL SURVIVAL RATE FROM 20% TO MORE THAN 80%, AND WE WON'T STOP UNTIL NO CHILD DIES FROM CANCER. TODAY, ST. JUDE IS LEADING THE WAY THE WORLD UNDERSTANDS, TREATS, AND DEFEATS CHILDHOOD CANCER AND OTHER LIFE-THREATENING DISEASES. ST. JUDE IS THE FIRST AND ONLY NATIONAL CANCER INSTITUTE-DESIGNATED COMPREHENSIVE CANCER CENTER DEVOTED SOLELY TO CHILDREN. ST. JUDE IS ALSO THE FIRST WORLD HEALTH ORGANIZATION (WHO) COLLABORATING CENTRE FOR CHILDHOOD CANCER. IN 2021, IN PARTNERSHIP WITH THE WHO, ST. JUDE ANNOUNCED A SIX-YEAR, $200 MILLION INITIATIVE TO INCREASE DELIVERY OF HIGH-QUALITY CHEMOTHERAPY MEDICINES FREE OF CHARGE TO CHILDREN IN LOW- AND MIDDLE-INCOME COUNTRIES. THIS REPRESENTS THE LARGEST FINANCIAL COMMITMENT EVER MADE FOR A GLOBAL EFFORT IN CHILDHOOD CANCER MEDICINES. IN 2021, A ST. JUDE CLINICAL TRIAL ANNOUNCED A SIGNIFICANT ADVANCEMENT IN OUTCOMES FOR CHILDREN WITH HIGH-RISK NEUROBLASTOMA. THIS NEW THERAPY, DEVELOPED AT ST. JUDE, DELIVERS AN INCREASE IN SURVIVAL RATES OF MORE THAN 20 PERCENTAGE POINTS, TO 74 PERCENT. PRIOR TO THIS BREAKTHROUGH, THE SURVIVAL RATE HAD REMAINED AT APPROXIMATELY 51 PERCENT FOR A DECADE. ST. JUDE SHARES BREAKTHROUGHS IT MAKES TO HELP DOCTORS AND RESEARCHERS AT LOCAL HOSPITALS AND CANCER CENTERS AROUND THE WORLD IMPROVE THE QUALITY OF TREATMENT AND CARE FOR EVEN MORE CHILDREN. IN ADDITION TO CHILDHOOD CANCER, ST. JUDE PLAYS A CRITICAL LEADERSHIP ROLE IN GROUNDBREAKING STUDIES ON SICKLE CELL DISEASE, INFECTIOUS DISEASES, AND GENETIC DISORDERS. THESE EFFORTS ARE INSTRUMENTAL TO IMPROVING CARE FOR CHILDREN AROUND THE WORLD. A ST. JUDE PATIENT WAS THE FIRST IN THE WORLD TO BE CURED OF SICKLE CELL DISEASE WITH A BONE MARROW TRANSPLANT, AND ST. JUDE HAS ONE OF THE LARGEST PEDIATRIC SICKLE CELL PROGRAMS IN THE COUNTRY. AND ST. JUDE'S EFFORTS DON'T END WHEN TREATMENT STOPS. THE ST. JUDE AFTER COMPLETION OF THERAPY (ACT) CLINIC IS THE LARGEST LONG-TERM FOLLOW-UP CLINIC FOR PEDIATRIC CANCER PATIENTS IN THE UNITED STATES AND ST. JUDE DOES THIS AT NO COST TO THE PATIENTS. THE CLINIC HELPS PATIENTS STAY HEALTHY AFTER ACTIVE TREATMENT ENDS AND HAS BEEN A PROTOTYPE FOR OTHER LONGER TERM FOLLOW-UP PROGRAMS. FORMER ST. JUDE PATIENTS ALSO ARE PARTICIPATING IN THE ST. JUDE LIFE STUDY, DESIGNED TO HELP ADULT SURVIVORS OF CHILDHOOD CANCER LEARN ABOUT ISSUES THAT AFFECT THEIR HEALTH AS WELL AS WAYS TO STAY HEALTHY. ST. JUDE IS ALSO HOME TO THE CHILDHOOD CANCER SURVIVOR STUDY, A COLLABORATIVE STUDY AMONG U.S. AND CANADIAN INSTITUTIONS THAT INCLUDES MORE THAN 20,000 CHILDHOOD CANCER SURVIVORS WITH THE AIM TO IMPROVE SURVIVORSHIP OUTCOME AND QUALITY OF LIFE. IN ADDITION, BRAIN TUMOR SCIENCE AND TECHNOLOGY AT ST. JUDE ARE AT THE CUTTING EDGE WORLDWIDE, AND ST. JUDE HAS ONE OF THE WORLD'S LEADING RESEARCH-BASED PEDIATRIC BRAIN TUMOR PROGRAMS. ST. JUDE IS THE COORDINATING CENTER OF THE NATIONAL PEDIATRIC BRAIN TUMOR CONSORTIUM, WHICH RECEIVES FUNDING FROM THE NATIONAL CANCER INSTITUTE. ST. JUDE'S COMMITMENT TO ADVANCING THE FRONTIERS OF RESEARCH IS EVIDENT IN THE 2021 OPENING OF THE $412M INSPIRATION4 ADVANCED RESEARCH CENTER (I4ARC), WHICH OFFERS SPACE FOR COMPUTATIONAL BIOLOGY, ARTIFICIAL INTELLIGENCE AND ONE OF THE MOST ADVANCED MICROSCOPES IN THE WORLD. IN ADDITION, THE I4ARC HOUSES LABS FOR IMMUNOLOGY, DEVELOPMENTAL NEUROBIOLOGY AND CELLULAR AND MOLECULAR BIOLOGY. THE CENTER CREATES AN INVITING SPACE FOR CLINICIANS, PHYSICIANS AND RESEARCH FROM ACROSS MULTIPLE DISCIPLINES TO COLLABORATE. FORM 990, PART V, LINE 4B (CONTINUED): THE FINANCIAL ACCOUNTS IN THE FOREIGN COUNTRIES LISTED ON FORM 990, PART V, LINE 4B (AND SCHEDULE O) ARE RELATED TO INVESTMENTS. NO FINANCIAL ACCOUNTS FOR OPERATIONAL PURPOSES WERE MAINTAINED IN FOREIGN COUNTRIES. FORM 990, PART VI, SECTION A, LINE 2 FAMILY RELATIONSHIP AMONG DIRECTORS: JOSEPH S. AYOUB, JR., ESQ. AND PAUL J. AYOUB, ESQ.; ROBERT A. BREIT, MD AND JOSEPH G. SHAKER; JOSEPH C. SHAKER AND JOSEPH G. SHAKER. BUSINESS RELATIONSHIP AMONG DIRECTORS: JOSEPH C. SHAKER AND JOSEPH G. SHAKER; ANN M. DANNER AND CHRISTINA M. RASHID. FORM 990, PART VI, SECTION B, LINE 11B IN THE THIRD QUARTER OF THE FISCAL YEAR, THE AUDIT & COMPLIANCE COMMITTEE ARE PROVIDED WITH A DRAFT COPY OF THE FORM 990 AND ALL REQUIRED SCHEDULES. THE AUDIT & COMPLIANCE COMMITTEE MEETS WITH ITS TAX PREPARER TO REVIEW THE DRAFT FORM 990 BEFORE IT IS FILED WITH THE IRS. ADDITIONALLY THE COMPENSATION COMMITTEE OF THE BOARD IS PROVIDED WITH A DRAFT COPY OF THE COMPENSATION SECTIONS OF THE FORM 990, AND THE CONFLICT OF INTEREST COMMITTEE OF THE BOARD IS PROVIDED WITH A DRAFT COPY OF THE CONFLICT-OF-INTEREST SECTIONS OF THE FORM 990 FOR REVIEW BEFORE THE FINALIZED DOCUMENT IS FILED WITH THE IRS. EACH VOTING MEMBER OF THE BOARD IS PROVIDED WITH A FINAL COPY OF THE FORM 990 AND ALL REQUIRED SCHEDULES BEFORE IT IS FILED WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C THE ORGANIZATION MAINTAINS A CONFLICT OF INTEREST COMMITTEE OF THE BOARD OF DIRECTORS. IN ADDITION TO EDUCATION OF NEW BOARD MEMBERS ON THE CONFLICT OF INTEREST POLICY, THE ADMINISTRATOR TO THE BOARD/CHIEF GOVERNANCE OFFICER MONITORS CONFLICT MANAGEMENT PLANS (WHICH MAY INCLUDE CHANGING VENDORS, DIVESTITURE OF FINANCIAL INTERESTS, AND THE LIKE) TO ENSURE THEY ARE COMPLETED IN A TIMELY FASHION. UNDISCLOSED CONFLICTS ARE DISCOVERED, WHERE POSSIBLE, THROUGH THE ORGANIZATION'S CONTRACTING PROCESS. THIS IS TRUE FOR THE BOARD'S CONFLICT OF INTEREST POLICY AND FOR THE SEPARATE CONFLICT OF INTEREST POLICY APPLICABLE TO ALL ADMINISTRATION OF THE ORGANIZATION (POTENTIAL CONFLICTS OF THE ORGANIZATION ARE DISCUSSED AND RESOLVED AT A SENIOR-LEVEL CONFLICTS OF INTEREST COMMITTEE). POTENTIAL RESTRICTIONS RANGE FROM UNWINDING OR PROHIBITING A TRANSACTION, TO PREVENTING SOMEONE FROM PARTICIPATING IN A DELIBERATION, TO SIMPLE DISCLOSURE TO THE BOARD OF THE CONFLICTING INTEREST, DEPENDING ON THE FACTS AND CIRCUMSTANCES OF THE CONFLICT. FORM 990, PART VI, SECTION B, LINE 15 THE COMPENSATION COMMITTEE ("COMMITTEE") OF THIS ORGANIZATION CONSISTS OF INDEPENDENT MEMBERS OF THE ORGANIZATION'S GOVERNING BOARD. THE COMMITTEE IS RESPONSIBLE FOR REGULARLY REVIEWING AND APPROVING TOTAL REMUNERATION PAID TO THE CEO, CERTAIN OTHER OFFICERS, AND CERTAIN OTHER EMPLOYEES. THE BOARD HAS ADOPTED A WRITTEN EXECUTIVE COMPENSATION PHILOSOPHY, WHICH THE COMMITTEE FOLLOWS WHEN IT REVIEWS AND APPROVES COMPENSATION AND BENEFITS. THE EXECUTIVE COMPENSATION PHILOSOPHY RECOGNIZES THE CRITICAL NEED TO HAVE AND RETAIN EXECUTIVES WHO CONSISTENTLY DEMONSTRATE SUPERIOR LEVELS OF PERFORMANCE SO THAT THE ORGANIZATION CAN FULFILL ITS CHARITABLE MISSION AND STRATEGIC OBJECTIVES. THE COMMITTEE APPROVES "TOTAL REMUNERATION," WHICH INCLUDES BOTH CURRENT AND DEFERRED COMPENSATION AND ALL EMPLOYEE BENEFITS, BOTH QUALIFIED AND NON-QUALIFIED, ON AT LEAST AN ANNUAL BASIS TO ENSURE THAT THE TOTAL COMPENSATION OF DISQUALIFIED PERSONS IS REASONABLE. TO ASSIST WITH THE REVIEW, THE COMMITTEE ENGAGES THE SERVICES OF A NATIONALLY RECOGNIZED INDEPENDENT CONSULTING FIRM SPECIALIZING IN EXECUTIVE COMPENSATION FOR NOT-FOR-PROFIT HEALTH CARE AND HEALTHCARE FUNDRAISING ORGANIZATIONS AND RECEIVES A REPORT SUMMARIZING NATIONAL AND REGIONAL MARKET DATA FOR COMPARABLE ORGANIZATIONS AND AN OPINION LETTER RELATING TO THE REASONABLENESS OF EACH REVIEWED EMPLOYEE'S TOTAL COMPENSATION AND BENEFITS. ADDITIONALLY, A SENIOR MEMBER OF THE CONSULTING FIRM ATTENDS THE COMMITTEE'S MEETINGS AS NECESSARY TO PROVIDE INFORMATION AND TO RESPOND TO QUESTIONS BY THE MEMBERS OF THE COMMITTEE. THE COMMITTEE'S PROCESS IS INTENTIONALLY STRUCTURED TO QUALIFY FOR THE REBUTTABLE PRESUMPTION UNDER SECTION 4958 OF THE INTERNAL REVENUE CODE OF 1986. THE COMPENSATION APPROVED BY THE COMMITTEE IS REPORTED IN EXECUTIVE SESSION TO THE FULL BOARD BY THE CHAIR AND VICE CHAIR OF THE COMMITTEE. FORM 990, PART VI, SECTION C, LINE 19 GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE AVAILABLE TO THE PUBLIC UPON REQUEST. FORM 990, PART IX, LINE 26: WE CONDUCT A NUMBER OF ACTIVITIES, WHICH JOINTLY BENEFIT OUR EDUCATION, TRAINING, AND COMMUNITY SERVICE PROGRAM OBJECTIVES, AS WELL AS FUNDRAISING AND GENERAL AND ADMINISTRATIVE ACTIVITIES. THE EDUCATIONAL INFORMATION SHARED WITHIN THESE ACTIVITIES SUPPORT OUR MISSION TO LEAD THE WAY THE WORLD UNDERSTANDS, TREATS AND DEFEATS CHILDHOOD CANCER AND OTHER LIFE-THREATING DISEASES AND INCLUDE OUR TELEVISION AND RADIO PROGRAMS AND PLACEMENTS, DIRECT MAIL PROGRAM, AND CERTAIN OTHER FUNDRAISING AND PUBLIC AWARENESS EVENTS. IN ACCORDANCE WITH THE FINANCIAL ACCOUNTING STANDARDS BOARD GUIDELINES, WE ALLOCATED A PORTION OF OUR FUNDRAISING EXPENSES TO PROGRAM SERVICE AND GENERAL AND ADMINISTRATIVE EXPENSES IN OUR COMBINED STATEMENTS OF FUNCTIONAL EXPENSES. ST JUDE CHILDREN'S RESEARCH HOSPITAL INC 262 DANNY THOMAS PLACE MEMPHIS TN 38105 640646012 HOSPITAL TN 501(C)(3) 3 N/A 0 MISSION PURE ALPHA FUND LP 75 PARK PLAZA STE 2 BOSTON MA 02116 871900700 INVESTMENT DE AMERICAN LEBANESE SYRIAN ASSOCIATED CHARITIES INC INVESTMENT -3503602 77858308 0 0 0.98700 TESTAMENTARY TRUSTS WITH VESTED RESIDUAL OR PERPETUAL INTERESTS (65) FIDUCIARY TN N/A T 1 0 1 1 0 0 0 0 0 0 1 0 1 0 1 0 1 1 0 0 TESTAMENTARY TRUSTS WITH VESTED RESIDUAL OR PERPETUAL INTERESTS (65) C 18205238 CASH OR CASH EQUIVALENT SCHEDULE R, PART IV: THE RELATED ENTITIES REPORTED ARE TESTAMENTARY TRUSTS IN WHICH ALSAC HAS A GREATER THAN 50% BENEFICIAL INTEREST. THE EIN AND STATE OF LEGAL DOMICILE VARY BY TRUST.